Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
In vivo biological standardization of Dermatophagoides, Betulaceae, and Graminaceae allergenic extracts
2012-001651-39Phase 2Completed
- Sponsor
- Lofarma S.p.A.
- Start
- Oct 2012
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label trial of allergenic extract of Dermatophagoides, allergenic extract of Betulaceae and allergenic extract of Graminaceae in inhalant allergy, seasonal allergic rhinitis (SAR) and house dust mite allergy (3 arms), sponsored by Lofarma S.p.A. Started Oct 2012; status: completed.
02
Drugs
allergenic extract of Dermatophagoidesallergenic extract of Betulaceaeallergenic extract of Graminaceae
03
Conditions
inhalant allergyseasonal allergic rhinitis (SAR)house dust mite allergy
Beyond the preview
Go deeper on 2012-001651-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001651-39.